Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
Venous Thrombosis Clinical Trials
A listing of Venous Thrombosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Dothan :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Montgomery :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Arizona
Glendale : Arrowhead Hospital/Phoenix Heart, PLLC
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Phoenix : Phoenix Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
Arkansas
California
La Mesa :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Long Beach :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Los Angeles :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Orange : St. Joseph Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Palo Alto : Stanford University Medical Center
Treatment of Blood Clots in Children With Cancer
View More »
San Diego :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
San Diego : Rady Children's Hospital UCSD
Evaluation of the Duration of Therapy for Thrombosis in Children
Santa Monica : UC Davis
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Stanford :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Stanford : Stanford University Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Colorado
Denver : University of Colorado School of Medicine
Evaluation of the Duration of Therapy for Thrombosis in Children
Wheat Ridge :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Connecticut
Danbury : Danbury Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Norwich : Eastern Connecticut Hematology and Oncology Associates
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Delaware
Newark : Christiana Care Health Systems
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
District of Columbia
Florida
Bay Pines :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Clearwater :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Clearwater :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Fort Myers :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Jacksonville :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Jacksonville : Nemours Children's Clinic/Jacksonville
Treatment of Blood Clots in Children With Cancer
Orlando : Florida Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Sarasota :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Sarasota :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
St. Petersburg : All Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
Tampa : Florida Hospital-Tampa Division-Pepin Heart Institute and Dr. Kiran C. Patel Research Institute
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Tampa : St. Joseph's Children's Hospital of TampaPediatric Hematology/Oncology Research Department
Treatment of Blood Clots in Children With Cancer
Vero Beach :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Georgia
Atlanta : Emory University
Treatment of Blood Clots in Children With Cancer
Decatur :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Jonesboro :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Illinois
Chicago : University of Illinois at Chicago
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Chicago :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Chicago : Rush University Medical Center
Treatment of Blood Clots in Children With Cancer
Hinsdale : Adventist Midwest Health
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Oak Park :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Winfield : Central DuPage Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Indiana
Carmel :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Indianapolis : CorVasc
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Lafayette :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Iowa
Iowa City : University of Iowa Carver's College of Medicine
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Windsor Heights :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Kansas
Topeka :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Kentucky
Florence : St. Elizabeth Healthcare of Northern Kentucky
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Louisville : Kosair Charities Pediatric Clinical Research Unit- University of Louisville
Treatment of Blood Clots in Children With Cancer
Paducah :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Louisiana
Covington :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Maine
Portland : Maine Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rockport : Penobscot Bay Medical Center
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Maryland
Annapolis :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Annapolis :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Baltimore : Johns Hopkins Bayview Medical Center
A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
Baltimore :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Randallstown :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Massachusetts
Boston : Massachusetts General Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Michigan
Ann Arbor : University of Michigan Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Ann Arbor : Ann Arbor Veteran's Administration Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Detroit :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Detroit : Henry Ford Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Detroit : Children's Hospital of Michigan, Wayne State University
Evaluation of the Duration of Therapy for Thrombosis in Children
View More »
East Lansing : Michigan State University
Evaluation of the Duration of Therapy for Thrombosis in Children
Minnesota
Duluth :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Rochester : Mayo Clinic
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Mississippi
Picayune :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Missouri
St. Louis :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
St. Louis : Washington University School of Medicine
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Montana
Butte :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Butte :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Nebraska
Lincoln : Saint Elizabeth Regional Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Omaha :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Nevada
Reno :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
New Jersey
Teaneck : Holy Name Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New Mexico
Albuquerque : University of New Mexico
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Albuquerque : University of New Mexico
Treatment of Blood Clots in Children With Cancer
New York
Buffalo : Roswell Park Cancer Institute
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
New York : Cornell Weill Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rochester : Rochester General Hospital
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Rochester : University of Rochester Medical Center
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Staten Island :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Staten Island : Staten Island University Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
North Carolina
Chapel Hill : University of North Carolina at Chapel Hill
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Durham :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Durham : Duke University School of Medicine
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Durham :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Durham : Duke University
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
View More »
Durham : Duke University
Evaluation of the Duration of Therapy for Thrombosis in Children
Durham : Duke Children's Hospital
Treatment of Blood Clots in Children With Cancer
Winston-Salem : Wake Forest University Baptist Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Ohio
Cincinnati : Good Samaritan Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Cleveland :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Cleveland : Cleveland Clinic
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Columbus : Riverside Methodist Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Columbus : Nationwide Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
View More »
Columbus :
Oral Rivaroxaban in Children With Venous Thrombosis
Columbus : Univeristy Medical Center
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Toledo : Jobst Vascular Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Oregon
Portland : Oregon Health & Science University
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Portland : Oregon Health and Science University
Treatment of Blood Clots in Children With Cancer
Pennsylvania
West Reading : Reading Hospital Clinical Trials Office
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
View More »
Bethlehem : St. Luke's Hospital and Health Network
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Camp Hill :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Camp Hill :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Ephrata :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Philadelphia : Albert Einstein Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Philadelphia : Temple University Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : The Western Pennsylvania Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : Allegheny General Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Sellersville :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
West Reading : The Reading Hospital and Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rhode Island
Providence : Rhode Island Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
South Carolina
Charleston : Medical University of South Carolina
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Charleston : Medical Center of South Carolina
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Orangeburg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Tennessee
Memphis : St. Jude Children's Research Hospital
Treatment of Blood Clots in Children With Cancer
Nashville : Vanderbilt University
Evaluation of the Duration of Therapy for Thrombosis in Children
Texas
Bellaire :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Corsicana :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Dallas :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Dallas : University of Texas Southwestern
Evaluation of the Duration of Therapy for Thrombosis in Children
Fort Worth : Cook Children's Hospital
Evaluation of the Duration of Therapy for Thrombosis in Children
View More »
Fort Worth : Cook Children's Medical Center
Treatment of Blood Clots in Children With Cancer
Houston : Texas Children's Cancer Center, Baylor College of Medicine
Evaluation of the Duration of Therapy for Thrombosis in Children
Houston : 1160.145.00001 Boehringer Ingelheim Investigational Site Updated
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
San Antonio :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Utah
Salt Lake City : University of Utah
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Virginia
Charlottesville : University of Virginia Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Fredericksburg :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Richmond :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Washington
Tacoma : MultiCare Health System
A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
View More »
Tacoma :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Wisconsin
Milwaukee : Medical College of Wisconsin/Froedtert Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Wauwatosa : Medical College of Wisconsin, Blood Center of Wisconsin
Evaluation of the Duration of Therapy for Thrombosis in Children
Australia
Herston :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Lismore :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Melbourne : Royal Melbourne hospital
The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
Parkville :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Redcliffe :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Sydney : Prince of Wales Hospital
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Austria
Graz :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Graz :
Oral Rivaroxaban in Children With Venous Thrombosis
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Wien :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Wien :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
View More »
Wien : 1160.89.43001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Belgium
Brussel : 1160.89.32003 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Brussels : CUB Hopital Erasme
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Bruxelles :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Ghent : Drug Research Unit Ghent
A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.
Huy :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Leper :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Leuven :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Yvoir :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Bulgaria
Gabrovo :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Pleven :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Sofia :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Canada
Ajax : Isis Investigational Site
Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS FXI Rx in Total Knee Arthroplasty
Edmonton :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Edmonton :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Edmonton : 1160.89.00002 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Greenfield Park :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
View More »
Halifax : CDHA-Queen Elizabeth II Health Science Centre
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Hamilton : Hamilton Health Sciences Corporation
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Hamilton :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Hamilton : St. Joseph's Healthcare Hamilton
The Risk of Venous Clotting in Patients After Renal Transplant
Hamilton : St Joseph's Healthcare Hamilton
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
London :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
London : Victoria Hospital
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Montreal :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Montreal : Hopital Sacre Coeur
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Montreal : St. Mary's Hospital - CHUM
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Montreal : McGill University Health Centre
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Montreal : SMBD Jewish General Hospital
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Montréal : Maisonneuve Rosemont Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
New Market :
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Oshawa : Isis Investigational Site
Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS FXI Rx in Total Knee Arthroplasty
Ottawa : Ottawa Hospital Research Institute (OHRI)
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Ottawa : Ottawa Health Research Institute
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Ottawa : 1160.89.00001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Quebec : Hopital Enfant Jesus
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Saskatoon : Saskatchewan Drug Research Institute
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Toronto : St. Michael's Hospital
Atorvastatin for the Treatment of Retinal Vein Occlusion
Toronto : University Health Network
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Toronto : 1160.89.00005 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Vancouver : Diamond Health Care Centre
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
Croatia
Krapinske Toplice :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Rijeka :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Zagreb :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Czech Republic
Kyjov :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Liberec :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Litomysl :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Olomouc :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Ostrava :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Praha 1 :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Praha 10 :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Usti nad Labem :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Zlin :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Denmark
Frederiksberg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Haderslev :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Hellerup :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Hillerod :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Hvidovre :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Kobenhavn NV :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Silkeborg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Slagelse :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Estonia
Tallinn :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Tartu :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
France
Angers : CHU d'Angers
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Angoulême : CH d'Angoulême
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Brest :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Brest : Centre Hospitalier Regional Universitaire de Brest
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Brest : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
View More »
Brest : HIA Clermont-Tonnerre
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Corbeil Essonne : CH de Corbeil Essonne
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Dijon : CHU de Dijon
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Dijon : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Grenoble : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Marseille : 1160.89.33002 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Montauban : CH Montauban
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Montelimar : Cabinet
Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
Morlaix : CH de Morlaix
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Paris : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Paris : Hopital Saint Louis
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Paris : 1160.89.33001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Poitiers : CHU de Poitiers
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Saint Malo : CH de St Malo
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Tours : CHU de Tours
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Germany
Baesweiler : Chriurgische Praxisklinik
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Berlin :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Berlin : MVZ Ramdohr, Praxis für Cardiovaskulär- u. Ultraschalldiagnostik
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Berlin : DEutsches Rotes Kreuz Schwesternschaft Berlin Gemeinnütziges Krankenhaus GmbH
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Bonn :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Bonn : Universitäts-Hautklinik Bonn
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Dresden :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Dresden : Krankenhaus Dresden-Friedrichstadt
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Dresden : Universitätsklinikum Dresden
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Eschwege : Gemeinschaftspraxis Eggeling und Winter
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Freiburg : Hautarztpraxis
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Görlitz : Oberlausitz-Gefäßpraxis
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Heidelberg : Universitätsklinikum Heidelberg
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Karlsbach : Akademie für Gefäßkrankheiten e.V.
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Köln : Praxis für Allgemeinmedizin un dPhlebologie
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Magdeburg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Magdeburg : Praxis Dr. Franke
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Mühldorf am Inn : Kardiologie Mühldorf am Inn
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
München : Gemeinschaftspraxis Mietaschk, Bilderling, Kaiser, Tato
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Neuss :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Rostock : Praxis Dr. Kähler
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Rottach-Egern : Praxis für Gefäßmedizin am Tegernsee
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Witten :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Hungary
Balassagyarmat :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
India
Nirmaya : Orange Lifesciences
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Pune : Sahyadri Speciality Hospital
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Shefali : Shefali Centre
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Surat : Jashvant Patel Clinic
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Israel
Afula :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Ashkelon :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Haifa :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Holon :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Jerusalem :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Kfar Saba :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Nahariya :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Safed :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Tel Aviv :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Tel Hashomer :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Zerifin :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Italy
Bollate :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Bologna : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Castelfranco Veneto :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Genova :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Milan : IRCCS H San Raffaele
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
View More »
Milano :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Parma :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Piacenza :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Roma :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Roma : 1160.89.39001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Torino :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Varese :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Vittorio Veneto TV :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Japan
Chuo-ku : St. Luke's International Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Fukushima : Fukushima Medical University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Hatsukaichi : Hiroshima General Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Itabashi-ku : Nihon University Itabashi Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Kitakyusyu : Kokura Memorial Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
View More »
Kumamoto : Kumamoto University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Kumamoto : Saiseikai Kumamoto Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Musashino : Japanese Red Cross Musashino Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Nagakute : Aichi Medical University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Okayama City : National Hospital Organization Okayama Medical Center
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Osakasayama : Kinki University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Sakura : Toho University Sakura Medical Center
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Sapporo : Teine Keijinkai Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Shinjuku-ku : Tokyo Medical University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Tsu : Mie University Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Yokohama : Yokohama Minami Kyousai Hospital
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
Korea, Republic of
Many Locations :
Xarelto Regulatory Post-Marketing Surveillance
Latvia
Daugavpils :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Liepaja :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Riga :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Riga : 1160.89.37101 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Valmiera :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Lithuania
Kaunas :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Klaipeda :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Siauliai :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Vilnius :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Vilnius : 1160.89.37001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Netherlands
Amsterdam : Academic Medical Center
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Nijmegen : 1160.89.31003 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Utrecht : 1160.89.31004 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Norway
Bergen : 1160.89.47001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Poland
Bialystok :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Bydgoszcz :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Czeladz :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Gdansk :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Krakow :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Skierniewice :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Tarnobrzeg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Warszawa :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Portugal
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Russian Federation
Kemerovo :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many locations :
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
Samara :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
St. Petersburg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Yaroslavl :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Singapore
Singapore :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Slovenia
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
South Africa
Cape Town :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Johannesburg :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Spain
Alicante : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Barcelona :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
L'Hospitalet de Llobregat :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Madrid :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Madrid :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
View More »
Madrid : 1160.89.34001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Madrid : 1160.89.34002 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Majadahonda :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Orihuela :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Sabadell :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
San Sebastián de los Reyes :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Sant Boi de Llobregat :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Soria : General Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Tarragona :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Sweden
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Stockholm : Karolinska University Hospital
Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture
Switzerland
Geneva : Hopitaux Universitaires de Geneve
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Zürich : 1160.89.41001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Thailand
Bangkok : 1160.89.66002 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Bangkok : 1160.89.66001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Khon Kaen : 1160.89.66003 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Tunisia
Tunis : Hospital Charle Nicolle
Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
Ukraine
Dnipropetrovsk : 1160.89.38001 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Lugansk : 1160.89.38002 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Vinnytsya : 1160.89.38003 Boehringer Ingelheim Investigational Site Updated
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
